Ecsedi Szilvia

1.

Koroknai, V., Szász, I., Hernandez, V. H., Fernandez, J. N., Cuenin, C., Herceg, Z., Vízkeleti, L., Ádány, R., Ecsedi, S., Balázs, M.: DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Exp. Dermatol. 29 (1), 39-50, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

2.

Balázs, M., Koroknai, V., Szász, I., Ecsedi, S.: Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization.
In: The Retinoblastoma Protein. Ed.: Pedro G. Santiago-Cardona, Springer Science+Business Media, New York, NY, 85-100, 2018. ISBN: 9781493975648

doi DEA

3.

Vízkeleti, L., Kiss, T., Koroknai, V., Ecsedi, S., Papp, O., Szász, I., Ádány, R., Balázs, M.: Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.

DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

4.

Koroknai, V., Ecsedi, S., Vízkeleti, L., Kiss, T., Szász, I., Lukács, A., Papp, O., Ádány, R., Balázs, M.: Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2, 100-107, 2016.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

5.

Balázs, M., Vízkeleti, L., Ecsedi, S., Ádány, R., Rásó, E., Hegedűs, B., Ladányi, A., Tóvári, J., Tímár, J.: Hazai melanomakutatások: reményt keltő eredmények egy korábban reménytelen daganatban.
Magyar Onkol. 59, 275-281, 2015.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q4 Oncology

6.

Kiss, T., Ecsedi, S., Vízkeleti, L., Koroknai, V., Emri, G., Kovács, N., Ádány, R., Balázs, M.: The role of osteopontin expression in melanoma progression.
Tumor Biol. 36 (10), 7841-7847, 2015.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

7.

Ecsedi, S., Hernandez, V. H., Lima, S. C., Vízkeleti, L., Tóth, R., Lázár, V., Koroknai, V., Kiss, T., Emri, G., Herceg, Z., Ádány, R., Balázs, M.: DNA methylation characteristics of primary melanomas with distinct biological behaviour.
PloS One. 9 (5), e96612, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

8.

Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernandez, V. H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., Balázs, M.: Integrative genomics identifies gene signature associated with melanoma ulceration.
PLoS One. 8 (1), e54958, 2013.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

9.

Ecsedi, S., Hernandez, V. H., Lima, S. C., Herceg, Z., Ádány, R., Balázs, M.: Transposable hypomethylation is associated with metastatic capacity of primary melanomas.
Int. J. Clin. Exp. Pathol. 6 (12), 2343-2348, 2013.

DEA

Journal metrics:

Q2 Histology

Q1 Pathology and Forensic Medicine

10.

Ecsedi, S., Tóth, L., Balázs, M.: Array CGH analysis of the rare laryngeal basaloid squamous cell carcinoma: a case report.
Int. J. Clin. Exp. Pathol. 5 (8), 834-839, 2012.

DEA

Journal metrics:

Q1 Histology

Q1 Pathology and Forensic Medicine

11.

Lázár, V., Ecsedi, S., Vízkeleti, L., Rákosy, Z., Boross, G., Szappanos, B., Bégány, Á., Emri, G., Ádány, R., Balázs, M.: Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Melanoma Res. 22 (3), 202-214, 2012.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

12.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Bégány, Á., Emri, G., Tóth, R., Orosz, A., Szöllősi, A. G., Méhes, G., Ádány, R., Balázs, M.: Prognostic relevance of the expressions of CAV1 and TES genes on 7q31 in melanoma.
Front Biosci (Elite Ed). E4 (1), 1802-1812, 2012.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Immunology and Microbiology (miscellaneous)

Q2 Medicine (miscellaneous)

13.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Orosz, A., Lázár, V., Emri, G., Koroknai, V., Kiss, T., Ádány, R., Balázs, M.: The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Tumor Biol. 33 (6), 2189-2199, 2012.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

14.

Balázs, M., Ecsedi, S., Vízkeleti, L., Bégány, Á.: Genomics of human malignant melanoma.
In: Breakthroughs in Melanoma Research. Ed.: Yohei Tanaka, InTech, Rijeka, 237-263, 2011. ISBN: 9789533072913

DEA

15.

Lázár, V., Ecsedi, S., Szöllősi, A. G., Tóth, R., Vízkeleti, L., Rákosy, Z., Bégány, Á., Ádány, R., Balázs, M.: Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
Mod. Pathol. 22 (10), 1367-1378, 2009.

doi DEA

Journal metrics:

D1 Pathology and Forensic Medicine

16.

Juhász, A., Sziklai, I., Rákosy, Z., Ecsedi, S., Ádány, R., Balázs, M.: Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Otol. Neurotol. 30 (4), 559-565, 2009.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

Q1 Neurology (clinical)

D1 Otorhinolaryngology

Q2 Sensory Systems

17.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Emri, G., Bégány, Á., Szöllősi, A. G., Méhes, G., Ádány, R., Balázs, M.: Expression alterations of genes located on the 7q31 region in human malignant melanomas.
Eur. J. Cancer. 35 (4), 218, 2009.

DEA

18.

Rákosy, Z., Vízkeleti, L., Ecsedi, S., Bégány, Á., Emri, G., Ádány, R., Balázs, M.: Characterization of the 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.
Cancer Genet. Cytogenet. 182 (2), 116-121, 2008.

doi DEA

Journal metrics:

Q3 Cancer Research

Q3 Genetics

Q3 Molecular Biology

19.

Ecsedi, S., Rákosy, Z., Vízkeleti, L., Juhász, A., Sziklai, I., Ádány, R., Balázs, M.: Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
Otolaryngol. Head Neck Surg. 139 (5), 635-640, 2008.

doi DEA

Journal metrics:

Q1 Otorhinolaryngology

Q1 Surgery

20.

Rákosy, Z., Bégány, Á., Barok, M., Krekk, Z., Gallai, M., Szentirmay, Z., Vízkeleti, L., Ecsedi, S., Vokó, Z., Ádány, R., Balázs, M.: EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
Int. J. Cancer. 121 (8), 1729-1737, 2007.

doi DEA

Journal metrics:

Q1 Cancer Research

Q1 Oncology

Ecsedi Szilvia

Publication list